Skip to content

Studies look at brain and cognitive changes in people with HIV as they age

D:A:D study – long-term use of darunavir/ritonavir modestly increases the risk of cardiovascular disease

Integrase inhibitors may increase risk of IRIS in late presenters for HIV treatment

Are people with HIV and HCV co-infection who are cured of hepatitis C with DAAs at increased risk for liver cancer?

Nicolás Merchante at CROI 2017. Photo by Liz Highleyman, hivandhepatitis.com

Better depression care could improve outcomes for HIV treatment programmes

Pamela Collins at CROI 2017. Photo credit: Robb Cohen Photography & Video

Prednisone reduces the risk of developing TB-IRIS after starting antiretroviral treatment

Graeme Meintjes at CROI 2017. Photo by Liz Highleyman, hivandhepatitis.com

Will there be a new wave of HIV in people who inject drugs in the US?

Sara Glick at CROI 2017. Photo by Liz Highleyman, hivandhepatitis.com

Three-drug regimen beats XDR-TB in first trial

Nix-TB patient in waiting area at Brooklyn Chest Hospital in Cape Town. Credit: John-Michael Maas for TB Alliance.

Stopping smoking cuts the risk of some cancers quickly in people with HIV

Leah Shepherd at CROI 2017. Photo by Liz Highleyman, hivandhepatitis.com